Plus Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Plus Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Plus Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Plus Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Plus Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Plus Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Richard J. Hawkins
Chairman Executive BoardMr. Richard J. Hawkins has been the Chairman of the company since 2018. Prior to this, he served as the Chief Executive Officer of Lumos Pharma Inc. Previously, he served as the Chairman, President and Chief Executive Officer of Pharmaco.
Marc H. Hedrick, M.D.
Chief Executive Officer; President; Director Executive BoardDr. Marc H. Hedrick has been the President, Chief Executive Officer, and Director of the company since 2014. Prior to this, he served as the Chief Scientific Officer and Medical Director of the company. Previously, he co-founded and served as the President and Chief Executive Officer of StemSource Inc.
Andrew Sims
Chief Financial Officer; Vice President Senior ManagementMr. Andrew J. Sims has been the Chief Financial Officer and Vice President of the company since 2020. Prior to this, he served in various roles at several private equity-backed companies. . Prior to this, he served as the Chief Financial Officer of Amplify LLC. Previously, he served as the Chief Financial Officer of Verbatim Support Services LLC.
Eric J. Daniels, M.D.
Chief Development Officer Senior ManagementMr. Eric J. Daniels has been the Chief Development Officer of the company since 2026. Previously, he served as Chief Executive Officer of OccuRx. He held senior leadership roles at Cytori Therapeutics, Inc.
Russell Bradley
General Manager - CNSide Diagnostics; President - CNSide Diagnostics Executive BoardStill looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer